The Effect of Interventions for Health Behaviors in Hypertensive Patients

Launched by NANJING MEDICAL UNIVERSITY · Oct 11, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at ways to help people with high blood pressure, also known as hypertension, improve their health behaviors. Hypertension is a common condition that can lead to serious health issues, so finding effective ways to manage it is very important. Researchers will use a specific plan called the PRECEED-PROCEED model to design and test different interventions aimed at helping patients make healthier choices. The goal is to see if these interventions can help people better control their blood pressure and stick to their treatment plans.

To participate in this study, you need to be between 18 and 80 years old and have been diagnosed with mild to moderate hypertension that isn’t well controlled. You should also be able to communicate and have lived in the community for at least a year. If you join the study, you’ll be part of a group that aims to improve health behaviors and get support from the research team. However, if you have difficulty with memory or communication, or if you're already involved in another study, you won’t be able to participate. This trial is currently recruiting participants, and it's an opportunity to contribute to important research that could help many people manage their hypertension better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients diagnosed with mild to moderate primary hypertension according to the diagnostic criteria of the "2018 Revised Edition of the Chinese Guidelines for the Prevention and Treatment of Hypertension," whose blood pressure is not well controlled or who have poor treatment compliance;
• • 2. Age greater than 18 years and less than 80 years;
• • 3. Normal language communication ability and willingness to participate in the study;
• • 4. Have lived in the community for at least 12 months.
• Exclusion Criteria:
• • 1. Patients who lack basic behavioral abilities, have impaired memory function, or have limited language expression abilities;
• • 2. Patients who are simultaneously participating in other intervention studies.